Jinxin Fertility, a company providing assisted reproductive technology services, received a strategic investment led by Warburg Pincus and CNCB Investment, a CITIC unit. Jinxin ranks second in China in terms of number of reproductive procedures performed. The company has centers in Chengdu, Shenzhen and the US, the latter providing services that are not available in China. Sequoia Capital China and WuXi AppTec also participated in the investment, whose size was not disclosed. Jinxin Fertility is headquartered in Chengdu, Sichuan Province.
Source: China Biotoday
